Literature DB >> 30188504

The definition of bronchopulmonary dysplasia: an evolving dilemma.

John Ibrahim1, Vineet Bhandari2.   

Abstract

The definition of bronchopulmonary dysplasia (BPD) continues to be a challenging one. The evolution of the disease as well as its definition are discussed. Limitations of the current as well as newer suggested definitions of BPD are summarized. Recognition of the variability of the pulmonary phenotype is a critical aspect of the disease that needs to identified, utilizing biomarkers that will potentially better inform the next iteration of the definition of BPD.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30188504     DOI： 10.1038/s41390-018-0167-9

Source DB:  PubMed          Journal:  Pediatr Res        ISSN： 0031-3998            Impact factor:   3.756


  8 in total

1.  Characterization of Disease Phenotype in Very Preterm Infants with Severe Bronchopulmonary Dysplasia.

Authors:  Katherine Y Wu; Erik A Jensen; Ammie M White; Yan Wang; David M Biko; Kathleen Nilan; María V Fraga; Laura Mercer-Rosa; Huayan Zhang; Haresh Kirpalani
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

2.  Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network.

Authors:  Cristina Ramos-Navarro; Elena Maderuelo-Rodríguez; Ana Concheiro-Guisán; Santiago Pérez-Tarazona; Santiago Rueda-Esteban; Ana Sánchez-Torres; Manuel Sánchez-Solís; Ester Sanz-López; Manuel Sánchez-Luna
Journal:  Eur J Pediatr       Date:  2021-10-01       Impact factor: 3.183

Review 3.  The Value of Lung Ultrasound Score in Neonatology.

Authors:  Haifeng Zong; Zhifeng Huang; Jie Zhao; Bingchun Lin; Yongping Fu; Yanqing Lin; Peng Huang; Hongyan Sun; Chuanzhong Yang
Journal:  Front Pediatr       Date:  2022-05-11       Impact factor: 3.569

4.  Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.

Authors:  Sudip Sheth; Lisa Goto; Vineet Bhandari; Boban Abraham; Anja Mowes
Journal:  J Perinatol       Date:  2019-11-13       Impact factor: 2.521

Review 5.  Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies.

Authors:  Kiersten Giusto; Heather Wanczyk; Todd Jensen; Christine Finck
Journal:  Dis Model Mech       Date:  2021-02-23       Impact factor: 5.758

6.  Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage.

Authors:  Juan Song; Yong Wang; Falin Xu; Huiqing Sun; Xiaoli Zhang; Lei Xia; Shan Zhang; Kenan Li; Xirui Peng; Bingbing Li; Yaodong Zhang; Wenqing Kang; Xiaoyang Wang; Changlian Zhu
Journal:  CNS Drugs       Date:  2021-05-06       Impact factor: 5.749

7.  Comparison of coenzyme Q10 or fish oil for prevention of intermittent hypoxia-induced oxidative injury in neonatal rat lungs.

Authors:  Christina D'Agrosa; Charles L Cai; Faisal Siddiqui; Karen Deslouches; Stephen Wadowski; Jacob V Aranda; Kay D Beharry
Journal:  Respir Res       Date:  2021-07-05

8.  Antileukotrienes for the prevention and treatment of chronic lung disease in very preterm newborns: a systematic review.

Authors:  Marlide Jukema; Franciszek Borys; Greta Sibrecht; Karsten Juhl Jørgensen; Matteo Bruschettini
Journal:  Respir Res       Date:  2021-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.